Exenatide Use in the Management of Type 2 Diabetes Mellitus

Exenatide Use in the Management of Type 2 Diabetes Mellitus

Exenatide is a GLP-1 (glucagon-like peptide-1) agonist that has been approved in the UK for use in the management of Type 2 Diabetes Mellitus (T2DM) since 2006. It acts by increasing glucose-induced insulin release and by reducing glucagon secretion postprandially. It therefore increases insulin sec...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Angelos Kyriacou, Abu Baker Ahmed
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: MDPI AG 2010-08-01
Sraith:Pharmaceuticals
Ábhair:
diabetes
exenatide
glycaemic control
incretin mimetics
efficacy
adverse events
Rochtain ar líne:http://www.mdpi.com/1424-8247/3/8/2554/

Ar líne

http://www.mdpi.com/1424-8247/3/8/2554/

Míreanna comhchosúla